21 State AGs Seek Waiver for Reproductive Telehealth Care
The federal government should let women use telehealth to access an abortion prescription drug Mifepristone during COVID-19, said Democratic attorneys general from California, 19 other states and the District of Columbia. Monday's letter urged the Department of Health and Human…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
Services and Food and Drug Administration to waive or not enforce its risk evaluation and mitigation strategy designation. “Forcing women to unnecessarily seek in-person reproductive healthcare during this public health crisis is foolish and irresponsible,” said California's Xavier Becerra (D). HHS didn't immediately comment. The federal government is facilitating other types of telehealth (see 2003300048).